作者：
Michela,Casanova [1]
;
Bernadette,Brennan [2]
;
Rita,Alaggio [3]
;
Anna,Kelsey [4]
;
Daniel,Orbach [5]
;
Max M,van Noesel [6]
;
Nadege,Corradini [7]
;
Veronique,Minard-Colin [8]
;
Ilaria,Zanetti [9]
;
Gianni,Bisogno [9]
;
Soledad,Gallego [10]
;
Johannes H M,Merks [11]
;
Gian Luca,De Salvo [12]
;
Andrea,Ferrari [13]
作者单位：
Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
[1]
Paediatric Oncology, Royal Manchester Children's Hospital, Manchester, United Kingdom.
[2]
Pathology Department, Ospedale Pediatrico Bambino Gesù IRCCS, Roma, Italy.
[3]
Department of Paediatric Histopathology, Royal Manchester Children's Hospital, Manchester, United Kingdom.
[4]
SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, PSL University, Paris, France.
[5]
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
[6]
Department of Pediatric Oncology, Institut d'Hematologie et d'Oncologie Pédiatrique, Centre Léon Bérard, Lyon, France.
[7]
Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.
[8]
Hematology and Oncology Division, Department of Women's and Children's Health, University of Padova, Padova, Italy.
[9]
Paediatric Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
[10]
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center Amsterdam, Netherlands.
[11]
Clinical Trials and Biostatistics Unit, IRCCS Istituto Oncologico Veneto, Padova, Italy.
[12]
Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy. Electronic address: andrea.ferrari@istitutotumori.mi.it.
[13]
DOI
10.1016/j.ejca.2019.12.021
PMID
32007712
发布时间
2020-07-31
换一批
换一批
